Assessment of myocardial viability by dobutamine echocardiography: An overview;Myokardialer vitalitatsnachweis mit der dobutamin-echokardiografie: Aktuelle ubersicht

Zeitschrift fur Kardiologie

Volumn 89, Issue 10, 2000, Pages 921-931

  Völler, Heinz ^a   Nixdorff, U ^b   Flachskampf, F A ^b  

^a Klinik am See   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Dobutamine stress echocardiography; Myocardial viability; Prognosis

Indexed keywords

DOBUTAMINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ARTICLE; BLOOD FLOW VELOCITY; CELL DEATH; CELL VIABILITY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HUMAN; MYOCARDIAL HIBERNATION; PROGNOSIS; REVASCULARIZATION; RISK ASSESSMENT; STUNNED HEART MUSCLE; SURVIVAL; TREATMENT PLANNING; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; ECHOGRAPHY; HEART MUSCLE; PATHOLOGY; PHYSIOLOGY; REVIEW;

CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; HUMANS; MYOCARDIAL STUNNING; MYOCARDIUM; PROGNOSIS; TISSUE SURVIVAL;

EID: 0033768708     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920070166     Document Type: Article

References (67)

1. Dobutamine echocardiography in myocardial hibernating: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
2. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: Evidence of myocardial stunning in patients with coronary artery disease
3. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients
4. 201TI single-photon emission computed tomography
5. Chronic ischemic viable myocardium in man: Aspects of de-differentiation
6. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography
7. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization
8. Determinants of reversible asynergy. Effect of pathologic Q-waves, coronary collaterals and anatomic location
9. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: Correlation with histopathology in explanted hearts
10. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
11. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography
12. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability
13. Mechanism of myocardial 'stunning'
14. Myocardial 'stunning' in man
15. The stunned myocardium: Prolonged, post-ischemic ventricular dysfunction
16. Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities
17. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction
18. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
19. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: Implications of time course of recovery on diagnostic accuracy
20. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography
21. Assessment of myocardial viability with (99m)Tc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function
22. Postextrasystolic potentiation of ischemic myocardium by atrial stimulation
23. Influence of subendocardial ischemia on transmural myocardial function
24. Hibernating myocardium: An incomplete adaptation to ischemia
25. Differential (18)F-2-deocyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: Evidence for chronic stunning in pigs
26. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: Determinants of reversible segmental asynergy postrevascularization surgery
27. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: Implications for the pathophysiology of chronic myocardial hibernation
28. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease
29. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ procine heart: Inotropic responses to postextrasystolic potentiation and intracoronary calcium
30. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs
31. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine
32. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease
33. Medical and cellular implications of stunning, hibernation, and preconditioning
34. Time course of myocardial viability after acute myocardial infarction: An echocardiographic study
35. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease
36. Echocardiography for the assessment of myocardial viability
37. Nitroglycerin enhances the ability of dobutamin stress echocardiography to detect hibernating myocardium
38. Histological alterations in chronically hypoperfused myocardium: Correlation with PET findings
39. Thallium-201 kinetics in stunned myocardium characterized by servere postischemic systolic dysfunction
40. Relation of the contractile reserve of hibernating myocardium structure in humans
41. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty
42. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction
43. 201TI tomography versus dobutamine echocardiography
44. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction
45. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography
46. Postextrasystolic potentiation as a predictor of potential myocardial viability: Preoperative analysis compared with studies after coronary bypass surgery
47. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis
48. 201Tl tomography in myocardial hibernation
49. The hibernating myocardium
50. Myocardial hibernation and stunning: From physiological principles to clinical practice
51. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: Evidence for cumulative stunning or ischaemic preconditioning?
52. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: A model of short-term hibernation
53. Development of short-term myocardial hibernation: 1st limitation by the severity of ischemia and inotropic stimulation
54. Indications for clinical application of positron emission tomography in cardiology
55. Myocyte degeneration and cell death in hibernating human myocardium
56. Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques
57. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure
58. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: Hibernation versus stunning?
59. Effect of ischemia and post-ischemic dysfunction on myocadial uptake of technetium-99m labeled methoxysobutyl isonitrile and thallium-201
60. Dobutamine-atropine stress echocardiography for reversible dysfunction during the first week after acute myocardial infarction: Limitations and determinant of accuracy
61. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction
62. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
63. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependet myocardium
64. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction
65. Determinants of 6 months mortality in survivors of myocardial infarction after thrombolysis
66. Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle: Implications for the mechanism of stunned myocardium
67. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction